查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1820152

2025-2033 年止咳糖浆市场报告，按产品类型（祛痰药、止咳药/镇咳药、复方药物）、年龄组（儿科、成人）、配销通路（零售药房、医院药房、网上药房）和地区划分

Cough Syrup Market Report by Product Type (Expectorants, Cough Suppressants/Antitussives, Combination Medications), Age Group (Pediatric, Adult), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球止咳糖浆市场规模达61亿美元。展望未来， IMARC Group预计到2033年，市场规模将达到85亿美元，2025-2033年期间的复合年增长率（CAGR）为3.65%。上呼吸道感染（URTI）和其他呼吸系统疾病的发生率不断上升，加上一般商店和药局中止咳糖浆的普及，是推动市场成长的主要因素。

全球止咳糖浆市场趋势：

日益严重的医疗状况

感冒、流感、支气管炎、百日咳、气喘、慢性肺阻塞性疾病 (COPD) 和过敏症的盛行率不断上升，推动了对止咳糖浆的需求。例如，根据《经济时报》 2023 年发表的一篇文章，全球约有 3.39 亿人患有气喘。此外，由于烟草消费增加和不健康的生活方式导致咳嗽病例增加，也刺激了市场成长。此外，根据世界卫生组织 (WHO) 的数据，每年有超过 800 万人因吸烟而过早死亡。其中，700 万人是直接吸烟者，170 万人是二手烟使用者。因此，政府和非政府组织正在启动许多计划和活动，以提高人民的意识。例如，2023 年 7 月，澳洲肺臟基金会发起了一项慢性咳嗽宣传运动，以提高成人和儿科的认识并支持诊断。除此之外，老年人口的不断成长也进一步推动了止咳糖浆市场的前景。例如，根据世界卫生组织的数据，2020年60岁及以上人口为10亿，预计2050年将达到21亿人。

政府机构的监管环境

各国监管机构正在实施严格的规定，以确保领先的止咳糖浆公司遵守高医疗标准。为此，他们正在提高医疗保健专业人员开发仿製药的意识，从而催化止咳糖浆市场的新机会。例如，印度药品监督管理局（DCGI）在致所有邦和联邦属地的一封信中要求确保印度生产的止咳糖浆符合全球品质标准，并应进行详细的验证。为此，他要求对丙二醇（PG）製造商、止咳糖浆製造商和进口商开展联合验证活动，以确保用于生产止咳糖浆的原料符合全球标准。此外，世界卫生组织（WHO）已将另一种止咳糖浆标记为含有污染物。世卫组织在2022年7月收到有关可能存在污染的报告后，对特定批次糖浆的样本进行了检测。 Fourrts Laboratories 代表印度另一家名为 Dabilife Pharma 的公司生产了这款止咳糖浆。这些严格的法规和检查将提高产品质量，预计将在未来几年推动止咳糖浆市场的收入成长。

策略联盟

知名的关键参与者正在进行併购，并不断致力于开发通常采用天然成分配製而成、具有增强免疫力作用的草药的新产品。这反过来又推动了市场向前发展。例如，2023 年，葛兰素史克公司与加拿大的一家生技公司 Bellus Health 签署了一项价值 20 亿美元的收购协议。这笔交易旨在加强葛兰素史克在全球的临床产品线组合和市场地位。该产品组合还包括糖浆和其他配方，从而提升了止咳糖浆的市场份额。同样，2023 年 12 月，美国 FDA 发布了关于默克公司针对 gefapixant 的新药申请 (NDA) 的完整回复函 (CRL)，gefapixant 是治疗成人难治性慢性咳嗽 (RCC) 的药物之一。主要参与者正在进一步推出含有天然成分的止咳糖浆，以扩大其消费者群，这是止咳糖浆市场的最新发展。例如，Vitae Health Innovation 推出了 VITATUSS，这是一款天然糖浆，由接骨木、百里香、蜀葵、锦葵和沙棘萃取物配製而成。同时，Sun Pharmaceutical Industries Ltd. 宣布推出一款名为 Chericof 12 的止咳糖浆。该公司表示，这是印度首款能够缓解长达 12 小时症状的处方止咳糖浆。

全球止咳糖浆市场区隔：

按产品类型细分：

  • 祛痰药
  • 止咳药/镇咳药
  • 联合用药

目前，止咳药/镇咳药占全球大部分市场份额

感冒和咳嗽相关症状通常透过使用非处方药 (OTC) 来控制。止咳药或镇咳药是用来控制和缓解咳嗽的药物。虽然许多镇咳药是非处方药，但也有少数镇咳药需要处方才能取得。镇咳药有各种剂型，例如胶囊、液体、片剂和糖浆。例如，一项双盲交叉试验比较了美国最广泛使用的止咳药之一右美沙芬与欧洲传统镇咳药可待因，该试验在16名慢性咳嗽患者中进行了主观和客观疗效评估。右美沙芬比可待因更能降低咳嗽强度，被大多数患者认为是更好的止痛药。这反过来又代表了推动止咳糖浆市场在该细分领域成长的关键因素。

按年龄组分类：

  • 儿科
  • 成人

成人目前占据最大的市场份额

由于不健康的生活方式和长期接触烟草，成年人常常患有慢性和急性咳嗽。例如，根据欧洲呼吸学会2020年发布的一项研究，约10%的成年人口因生活品质下降而患有慢性咳嗽。因此，不断增长的成年人口正在推高止咳糖浆市场的需求，从而刺激止咳药的普及。

按配销通路细分：

  • 零售药局
  • 医院药房
  • 网路药局

目前，零售药局在市场上占据明显主导地位

根据止咳糖浆市场概况，由于零售药局等分销管道的便利性和可及性，产品易于获取，这推动了细分市场的成长。例如，根据德国药剂师协会联邦联盟 (ABDA) 的数据，2023 年，德国约有 18,068 家社区药局满足医疗需求。此外，沃尔玛和沃尔格林等零售连锁药局中仿製药和品牌药数量的不断增加，也成为另一个重要的成长驱动因素。此外，医院与这些连锁药局的合作日益密切，也支撑了止咳糖浆市场的近期价格。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

根据止咳糖浆市场统计数据，亚太地区在市场上占据明显主导地位

这份市场研究报告也对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告显示，亚太地区占据了最大的市场份额。

区域市场主要由製药公司和政府机构之间的许多合作推动，这些合作通常旨在开发新型仿製药，并提高个人和医疗保健专业人士的认知度。此外，主要参与者正致力于创新包装解决方案，这也促进了市场的成长。此外，该地区个人消费能力的不断提升以及对预防性医疗保健的日益重视，进一步验证了止咳糖浆市场的预测。根据快速消费品专家 (FMCG Gurus) 的报告，自从新冠疫情 (COVID-19) 突然爆发以来，亚太地区超过 55% 的民众更加重视增强免疫力。

竞争格局：

市场研究报告对竞争格局进行了全面的分析，并提供了所有主要公司的详细资料。市场中的一些主要参与者包括：

  • Acella製药有限责任公司
  • 拜耳公司
  • 葛兰素史克公司
  • 强生公司
  • 辉瑞公司
  • Prestige消费者保健公司
  • 利洁时集团
  • 赛诺菲
  • 太阳製药工业有限公司
  • 宝洁公司

本报告回答的关键问题

  • 2024 年全球止咳糖浆市场规模是多少
  • 2025-2033年全球止咳糖浆市场的预期成长率是多少
  • COVID-19 对全球止咳糖浆市场有何影响
  • 推动全球止咳糖浆市场的关键因素有哪些
  • 根据产品类型，全球止咳糖浆市场如何划分
  • 全球止咳糖浆市场按年龄分類的情况如何
  • 根据配销通路，全球止咳糖浆市场如何划分
  • 全球止咳糖浆市场的主要区域有哪些
  • 全球止咳糖浆市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 2024年全球止咳糖浆市场规模？ 2025-2033年全球止咳糖浆市场的预期成长率是多少？
  • COVID-19 对全球止咳糖浆市场有何影响？
  • 推动全球止咳糖浆市场发展的关键因素有哪些？
  • 根据产品类型，全球止咳糖浆市场是如何分布的？
  • 根据年龄组，全球止咳糖浆市场是如何分布的？
  • 根据配销通路，全球止咳糖浆市场如何分布？
  • 全球止咳糖浆市场的主要地区有哪些？
  • 全球止咳糖浆市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球止咳糖浆市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 祛痰药
  • 止咳药/镇咳药
  • 联合用药

第七章：市场区隔：依年龄段

  • 儿科
  • 成人

第八章：市场区隔：按配销通路

  • 零售药局
  • 医院药房
  • 网路药局

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Acella Pharmaceuticals LLC
    • Bayer AG
    • GlaxoSmithKline PLC
    • Johnson & Johnson
    • Pfizer Inc.
    • Prestige Consumer Healthcare Inc.
    • Reckitt Benckiser Group PLC
    • Sanofi
    • Sun Pharmaceutical Industries Limited
    • The Procter & Gamble Company
Product Code: SR112025A3917

The global cough syrup market size reached USD 6.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.65% during 2025-2033. The increasing occurrence of upper respiratory tract infections (URTIs) and other respiratory disorders, along with the easy availability of cough syrups in general stores and pharmacies, is primarily driving the market growth.

Global Cough Syrup Market Trends:

Growing Medical Conditions

The rising prevalence of cold, flu, bronchitis, pertussis, asthma, chronic pulmonary obstructive disease (COPD), and allergies is driving the need for cough syrups. For example, according to an article published by the Economic Times in 2023, around 339 million individuals are affected by asthma globally. Furthermore, the elevating cough cases, owing to the increasing tobacco consumption and unhealthy lifestyles, are also stimulating the market growth. Besides this, as per the World Health Organization (WHO), every year, more than 8 million people die prematurely from tobacco consumption. Among these, 7 million are direct smokers, and 1.7 million are second-hand smokers. Consequently, government and non-government organizations are launching numerous programs and campaigns to generate awareness among the population. For example, in July 2023, the Lung Foundation in Australia launched a chronic cough awareness campaign to raise awareness and support diagnosis in adults and pediatrics. In addition to this, the expanding geriatric population is further contributing to the cough syrup market outlook. For instance, according to the WHO, individuals aged 60 and above were 1 billion in 2020 and are expected to reach 2.1 billion by 2050.

Regulatory Environment by Government Bodies

Regulatory authorities across countries are implementing stringent rules to ensure leading companies of cough syrups comply with high medical standards. In line with this, they are generating awareness among healthcare professionals to develop generic drugs, thereby catalyzing the cough syrup market recent opportunities. For instance, in a letter written to all states and union territories, the Drugs Controller General of India (DCGI) asked to ensure that cough syrups produced in India are of global standard quality for which a detailed verification should be undertaken. In line with this, he asked for a joint verification drive on propylene glycol (PG) manufacturers, cough syrup manufacturers, and importers to ensure that the raw material utilized or supplied for the manufacturing of cough syrups is as per the global protocol. Additionally, the World Health Organization (WHO) has flagged another cough syrup for the presence of contaminants. The WHO tested a sample from a specific batch of the syrup after it received a report in July 2022 regarding possible contamination. Fourrts Laboratories produced the cough syrup on behalf of another company in India called Dabilife Pharma. These stringent regulations and checks will improve the quality of products, which is expected to propel the cough syrup market revenue in the coming years.

Strategic Alliances

Prominent key players are entering into mergers and acquisitions and are constantly working towards novel product developments that are usually formulated with natural ingredients and herbs with immunity-boosting effects. This, in turn, is driving the market forward. For example, in 2023, GSK plc. signed an acquisition deal with one of the Biotech firms in Canada, Bellus Health, for US$ 2 Billion. This deal was done to strengthen GSK's clinical pipeline portfolio and market position across the globe. The portfolio also included syrups and other formulations, thereby elevating the cough syrup market share. Similarly, in December 2023, the U.S. FDA issued a complete response letter (CRL) about Merck's new drug application (NDA) for gefapixant, one of the drugs to treat refractory chronic cough (RCC) in adults. Key players are further introducing cough syrups with natural ingredients to expand their consumer base, which is cough syrup market recent developments. For instance, Vitae Health Innovation launched VITATUSS, a natural syrup formulated with elderberry, thyme, althaea, mallow, and sea buckthorn extract. In line with this, Sun Pharmaceutical Industries Ltd. announced the introduction of a formulation in cough management called Chericof 12. The company said this was the first prescription cough syrup across India that offer relief for up to 12 hours.

Global Cough Syrup Market Segmentation:

Breakup by Product Type:

  • Expectorants
  • Cough Suppressants/Antitussives
  • Combination Medications

Currently, cough suppressants/antitussives account for the majority of the global market share

Symptoms related to cold and cough are usually managed by utilizing over the counter (OTC) medicines. Cough suppressants, or antitussive drugs, are medicines that are adopted to control and relieve a cough. While many antitussives are widely accessible OTC, a few antitussives are only available with a prescription. Antitussives are used in various types of formulations, such as capsules, liquids, tablets, and syrups. For example, Dextromethorphan, one of the most widely utilized cough suppressants in the U.S., was compared with codeine, the traditional antitussive in Europe, in a double-blind, crossover trial using both subjective and objective assessment of efficacy in sixteen patients with chronic cough. Dextromethorphan lowered cough intensity more than codeine and was considered the better antitussive by most patients. This, in turn, represents key factors propelling the cough syrup market growth in the segmentation.

Breakup by Age Group:

  • Pediatric
  • Adult

Adult currently holds the largest market share

Adults commonly suffer from chronic and acute cough, owing to unhealthy lifestyles and high exposure to tobacco. For example, as per the study published by the European Respiratory Society in 2020, approximately 10% of the adult population suffers from chronic cough, on account of the impaired quality of life. Consequently, the expanding adult population is escalating the cough syrup market demand, thereby stimulating the adoption of cough remedies.

Breakup by Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Currently, retail pharmacy exhibits a clear dominance in the market

As per the cough syrup market overview, the easy product availability via distribution channels, such as retail pharmacy, owing to its accessibility and convenience, is bolstering the segmentation growth. For example, according to the Federal Union of German Associations of Pharmacists (ABDA, around 18,068 community pharmacies across Germany cater to medical needs in 2023. In addition to this, the rising number of generic and branded remedy products in retail pharmacy chains, including Walmart Stores Inc. and Walgreens, is further acting as another significant growth-inducing factor. Moreover, the increasing tie-ups of hospitals with these chains are strengthening the cough syrup market recent price.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

According to the cough syrup market statistics, Asia Pacific exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share.

The regional market is primarily driven by the numerous partnerships among pharmaceutical companies and government organizations, generally to develop novel generic drugs and generate awareness among individuals and healthcare professionals. Moreover, key players are emphasizing on innovative packaging solutions, which is contributing to the growth of the market. Apart from this, the inflating expenditure capacities of individuals across the region and the elevating focus on preventive healthcare are further validating the cough syrup market forecast. According to a report by the FMCG Gurus, more than 55% of people in the Asia Pacific region have been more conscious about boosting their immunity since the sudden outbreak of the COVID-19 pandemic.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Acella Pharmaceuticals LLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • The Procter & Gamble Company

Key Questions Answered in This Report

  • 1.What was the size of the global cough syrup market in 2024?
  • 2.What is the expected growth rate of the global cough syrup market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global cough syrup market?
  • 4.What are the key factors driving the global cough syrup market?
  • 5.What is the breakup of the global cough syrup market based on the product type?
  • 6.What is the breakup of the global cough syrup market based on the age group?
  • 7.What is the breakup of the global cough syrup market based on the distribution channel?
  • 8.What are the key regions in the global cough syrup market?
  • 9.Who are the key players/companies in the global cough syrup market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cough Syrup Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Expectorants
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cough Suppressants/Antitussives
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Combination Medications
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Pediatric
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Adult
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Acella Pharmaceuticals LLC
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 GlaxoSmithKline PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Pfizer Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Prestige Consumer Healthcare Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Reckitt Benckiser Group PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sanofi
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sun Pharmaceutical Industries Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 The Procter & Gamble Company
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cough Syrup Market: Major Drivers and Challenges
  • Figure 2: Global: Cough Syrup Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cough Syrup Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Cough Syrup Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Cough Syrup Market: Breakup by Age Group (in %), 2024
  • Figure 6: Global: Cough Syrup Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Cough Syrup Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Cough Syrup (Expectorants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Cough Syrup (Expectorants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Cough Syrup (Cough Suppressants/Antitussives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Cough Syrup (Cough Suppressants/Antitussives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Cough Syrup (Combination Medications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Cough Syrup (Combination Medications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Cough Syrup (Pediatric) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Cough Syrup (Pediatric) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Cough Syrup (Adult) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Cough Syrup (Adult) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Cough Syrup (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Cough Syrup (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Cough Syrup (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Cough Syrup (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Cough Syrup (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Cough Syrup (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: United States: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: United States: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Canada: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Canada: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Asia-Pacific: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: China: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: China: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Japan: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Japan: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: India: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: India: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: South Korea: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: South Korea: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Australia: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Australia: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Indonesia: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Indonesia: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Others: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Others: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Europe: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Europe: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Germany: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Germany: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: France: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: France: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United Kingdom: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United Kingdom: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Italy: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Italy: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Spain: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Spain: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Russia: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Russia: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Latin America: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Latin America: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Brazil: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Brazil: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Mexico: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Mexico: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Middle East and Africa: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Middle East and Africa: Cough Syrup Market: Breakup by Country (in %), 2024
  • Figure 72: Middle East and Africa: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Global: Cough Syrup Industry: SWOT Analysis
  • Figure 74: Global: Cough Syrup Industry: Value Chain Analysis
  • Figure 75: Global: Cough Syrup Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cough Syrup Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cough Syrup Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Cough Syrup Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 4: Global: Cough Syrup Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Cough Syrup Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Cough Syrup Market: Competitive Structure
  • Table 7: Global: Cough Syrup Market: Key Players